Cadila Healthcare falls as rival's COVID-19 vaccine gets nod for emergency use on adolescents
Prior to Biological E, Cadila Healthcare and Bharat Biotech's Covaxin had received the regulator's emergency approval for use on young adults.22-02-2022
22-02-2022
CADILA HEALTHCARE LTD. - 532321 - Trasnscript
Transcript of the 2nd Extra Ordinary General Meeting of the Financial Year 2021-2022 of the members of the Company held on February 18, 202221-02-2022
CADILA HEALTHCARE LTD. - 532321 - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Cadila Healthcare Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here18-02-2022
CADILA HEALTHCARE LTD. - 532321 - Outcome Of Second EOGM Of The Company Held On February 18, 2022.
Outcome of Second EOGM of the Company held on February 18, 2022.18-02-2022
CADILA HEALTHCARE LTD. - 532321 - Intimation Of Voting Results Of Second EOGM Of The Company Under Regulation 44(3).
Intimation of voting Results of second EOGM of the Company under Regulation 44(3).18-02-2022
CADILA HEALTHCARE LTD. - 532321 - Proceedings Of Second Extra Ordinary General Meeting Of The Members Of The Company Held On February 18, 2022.
Proceedings of Second Extra Ordinary General Meeting of the members of the Company held on February 18, 2022.18-02-2022
CADILA HEALTHCARE LTD. - 532321 - Intimation Of Consolidated Results On Voting Of 2Nd EOGM Of The Company.
Intimation of Consolidated Results on voting of 2nd EOGM of the Company.18-02-2022
CADILA HEALTHCARE LTD. - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of share certificate18-02-2022
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus gets 180 day shared exclusivity for Roflumilast Tablets14-02-2022
CADILA HEALTHCARE LTD. - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate / issue of duplicate share certificate under regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)11-02-2022